NRC HEALTH
For the period ended Mar 31, 2025. Filed May 9, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 9, 2025
NRC$26.85+0.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Income
(In thousands, except for per share amounts, unaudited)
| Three months ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Revenue | $33,551 | $35,313 |
| Operating expenses: | ||
| Direct | 13,057 | 13,856 |
| Selling, general and administrative | 10,356 | 11,250 |
| Depreciation and amortization | 1,542 | 1,447 |
| Total operating expenses | 24,955 | 26,553 |
| Operating income | 8,596 | 8,760 |
| Other income (expense): | ||
| Interest income | 19 | 44 |
| Interest expense | (899) | (605) |
| Other, net | 7 | (5) |
| Total other expense | (873) | (566) |
| Income before income taxes | 7,723 | 8,194 |
| Provision for income taxes | 1,936 | 1,835 |
| Net income | $5,787 | $6,359 |
| Earnings Per Share of Common Stock: | ||
| Basic Earnings Per Share | $0.25 | $0.27 |
| Diluted Earnings Per Share | $0.25 | $0.27 |
| Weighted average shares and share equivalents outstanding: | ||
| Basic | 22,972 | 23,868 |
| Diluted | 22,974 | 23,963 |
See accompanying notes to condensed consolidated financial statements
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.